Table 2.

Correlations of the basal microvilli parameters with clinicopathological variables in the pancreatic cancer patients.

	BMD1		BMD2		BML1		BML2		BMI1		BMI2
	r	p	r	p	r	p	r	p	r	p	r	p
Gender, male versus female	0.1	0.313	0.083	0.404	0.154	0.12	0.175	0.077	0.125	0.209	0.107	0.282
Age, >60 versus <60	−0.034	0.735	−0.065	0.512	−0.029	0.733	−0.02	0.84	−0.022	0.089	−0.042	0.676
Tumor size	−0.061	0.54	−0.86	0.388	0.143	0.149	0.159	0.109	0.023	0.818	0.03	0.763
RLM (yes versus no)	0.409	<0.001	0.416	<0.001	0.315	0.001	0.299	0.002	0.413	<0.001	0.409	<0.001
TNM stage	0.307	0.003	0.338	<0.001	0.412	<0.001	0.422	<0.001	0.377	<0.001	0.377	<0.001
PNI (yes versus no)	0.11	0.268	0.068	0.492	−0.72	0.472	−0.69	0.488	0.029	0.772	0.011	0.915
MVI (yes versus no)	0.059	0.552	0.07	0.48	0.253	0.01	0.233	0.018	0.164	0.098	0.159	0.108
Tumor vascular thrombus (yes versus no)	0.293	0.003	0.294	0.003	0.275	0.005	0.289	0.003	0.334	0.001	0.334	0.001
Resection margin (R1 versus R0)	0.051	0.606	0.105	0.293	0.218	0.027	0.233	0.018	0.133	0.179	0.155	0.118
CA 19‐9 (positive versus negative)	0.022	0.826	−0.04	0.97	−0.15	0.882	0.01	0.92	0.013	0.894	0.015	0.879
CEA (positive versus negative)	0.054	0.585	0.039	0.694	0.152	0.125	0.146	0.142	0.11	0.27	0.068	0.493
Ki67 index	0.19	0.056	0.205	0.038	0.186	0.061	0.21	0.034	0.232	0.019	0.245	0.013
Fasting blood glucose	0	0.999	0.013	0.898	0.096	0.338	0.096	0.338	0.048	0.629	0.065	0.52
Serum albumin levels	0.084	401	0.107	0.283	0.019	0.847	0.023	0.819	0.071	0.477	0.078	0.433

Spearman correlation, r, correlation efficiency; fasting blood glucose, before surgery; serum albumin levels, before surgery; tumor size, the largest diameters. BMD, basal microvilli density; BML, basal microvilli length; BMI, basal microvilli index; 1, mean; 2, median.

Bold font indicates statistically significant values.